Want to see OMID full AI Analyst Report?
Top Page
OMID Holdings
(OTC:OMID)
Select Model
Select Model
Rating:42Neutral
Price Target:―
Action:N/A
Date:01/03/25
OMID Holdings is facing significant financial and operational challenges, reflected in poor financial performance and negative valuation metrics. Technical analysis indicates bearish momentum, and the absence of strong earnings call insights adds to the uncertainty. The overall score reflects these challenges, highlighting the need for improved operational efficiency and revenue growth.
Positive Factors
Revenue Growth
OMID Holdings has demonstrated significant revenue growth, which indicates strong market demand and effective sales strategies, potentially leading to increased market share and long-term business expansion.
Negative Factors
High Leverage
High leverage can strain financial resources, limiting flexibility and increasing vulnerability to economic downturns, which could impact long-term sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
OMID Holdings has demonstrated significant revenue growth, which indicates strong market demand and effective sales strategies, potentially leading to increased market share and long-term business expansion.
Read all positive factors
OMID Holdings (OMID) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.12M
Dividend YieldN/A
Average Volume (3M)7.53K
Price to Earnings (P/E)―
Beta (1Y)2.54
Revenue Growth59.18%
EPS Growth79.55%
CountryUS
Employees6
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding96,355,120
10 Day Avg. Volume14,274
30 Day Avg. Volume7,533
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)34.91
Price to Sales (P/S)7.09
P/FCF Ratio-21.46
Enterprise Value/Market Cap1.52
Enterprise Value/Revenue8.15
Enterprise Value/Gross Profit-48.46
Enterprise Value/Ebitda-9.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)$12.00M
OMID Holdings Business Overview & Revenue Model
Company Description
OMID Holdings, Inc. operates as a company within the health and wellness sector, specializing in the creation and distribution of products infused with CBD. The firm's main offices are situated in Phillipsburg, New Jersey....
How the Company Makes Money
OMID Holdings generates revenue primarily through the sale of its hemp and CBD-based products. These products are distributed through various retail and online channels, allowing the company to reach a broad consumer base. Key revenue streams incl...
OMID Holdings Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Dec 2025 | Dec 2024 | Sep 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 394.12K | 247.59K | 522.24K | 1.55M | 2.15M |
| Gross Profit | -66.28K | -275.31K | 60.21K | -87.82K | 853.70K |
| EBITDA | -298.52K | -476.25K | 57.40K | -444.86K | 559.95K |
| Net Income | -177.93K | -850.59K | 34.64K | -330.53K | 484.05K |
Balance Sheet | |||||
| Total Assets | 418.33K | 828.01K | 818.02K | 912.49K | 1.68M |
| Cash, Cash Equivalents and Short-Term Investments | 292.04K | 646.08K | 137.82K | 469.94K | 931.38K |
| Total Debt | 324.49K | 333.97K | 342.86K | 339.57K | 351.18K |
| Total Liabilities | 338.28K | 378.78K | 402.44K | 592.39K | 1.04M |
| Stockholders Equity | 80.05K | 449.23K | 415.58K | 320.10K | 639.40K |
Cash Flow | |||||
| Free Cash Flow | -130.20K | -367.10K | -427.70K | -478.75K | 307.50K |
| Operating Cash Flow | -130.19K | -367.10K | -408.04K | -420.87K | 341.07K |
| Investing Cash Flow | 35.17K | -64.34K | -19.66K | -57.88K | -33.57K |
| Financing Cash Flow | -11.97K | 563.04K | 56.73K | 68.42K | 227.94K |
OMID Holdings Technical Analysis
Negative
0.02
Price Trends
0.03
Negative
0.03
Negative
0.03
Negative
Market Momentum
>-0.01
Negative
37.41
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OMID, the sentiment is Negative. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 37.41 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OMID.
OMID Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | $44.87M | -1.65 | -92.47% | ― | -100.00% | 54.21% | |
44 Neutral | $5.80M | -1.70 | -33.59% | ― | 10.01% | 95.01% | |
42 Neutral | $2.12M | -13.75 | ― | ― | 59.18% | 79.55% | |
37 Underperform | $981.00K | -1,062.50 | -3.03% | ― | -11.91% | -285.23% |
* Healthcare Sector Average
OMID
OMID Holdings
0.02
<0.01
22.22%
YCBD
cbdMD
0.52
-0.26
-33.33%
IMCC
IM Cannabis Corp
0.11
-2.33
-95.45%
IXHL
Incannex Healthcare Limited Sponsored ADR
3.70
-14.84
-80.04%
AKAN
Akanda Corp
4.24
-86.44
-95.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.